FrontPoint Healthcare Manager Shukla To Citi V.C. Arm

Jun 3 2011 | 12:46pm ET

A Citigroup venture capital and private equity division is the latest to take advantage of FrontPoint Partners' difficulties. Citi Venture Capital International has hired Rajiv Shukla, the former co-head of FrontPoint's emerging markets healthcare fund.

Shukla will work at CVCI's captive private equity arm, VCCircle reports, handling new investments.

CVCI focuses on developing markets, which are Shukla's specialty. He joined FrontPoint last March to co-manage its new emerging markets healthcare vehicle from Indian private equity firm ICICI Venture, and formerly worked at Pfizer and Avendus Capital.

Shukla's time at FrontPoint came to a crashing halt when his co-manager, Joseph Skowron, the head of FrontPoint's healthcare funds, was accused of insider-trading. FrontPoint shuttered its $1.5 billion healthcare funds and cut the entire team at the beginning of November.

Skowron has since been charged with insider-trading, and FrontPoint last month announced that it would close most of its hedge funds, including its flagship multi-strategy fund.


In Depth

Israeli Hedge Fund Harnesses Big Data

Jul 28 2014 | 8:10am ET

Apica Green is a multi-million dollar Israeli hedge fund that is based in Tel Aviv...

Lifestyle

David Yarrow On Growing His Hedge Fund And Shooting The Animals And People Of Africa - As A Photographer

Jul 23 2014 | 6:44am ET

While he’s always been a photographer, recent expeditions to Iceland, Ethiopia...

Guest Contributor

The Truth About Track Record Portability

Jul 24 2014 | 5:55am ET

The number of private funds converting to mutual funds has increased significantly...

 

Sponsored Content

    Northern Trust Helps Hedge Funds Navigate Derivatives Regulations

    Jul 8 2014 | 10:48am ET

    The surge in derivatives regulation is among the most complex challenges facing the financial services industry today. Northern Trust’s Joshua Satten recently spoke with FINalternatives to share insights into the challenges presented by new regulation and explore how the industry is responding. Read more…

Publisher's Note